UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Breast implant infections

Authors
Tahaniyat Lalani, MBBS, MHS
Michael R Zenn, MD, FACS
Daniel J Sexton, MD
Section Editor
Stephen B Calderwood, MD
Deputy Editor
Allyson Bloom, MD

INTRODUCTION

Breast augmentation (also called augmentation mammoplasty) is the most common type of cosmetic surgery procedure in the United States, with almost 286,000 procedures being performed in 2014. This has been stable since 2005 [1]. Breast implants are performed both for breast enlargement and, in women who have undergone mastectomy for breast cancer, for breast reconstruction. (See "Implant based breast reconstruction and augmentation", section on 'Types of implants'.)

Today, silicone implants are the gold standard and used by most surgeons. Saline filled breast implants used to be the main prostheses used for breast augmentation. Although silicone gel implants provide a more natural appearance and feel, unfounded concerns about risk of connective tissue disease associated with silicone implants led to a moratorium on their use in the United States in 1992. This was lifted in November 2006, after further studies led to the conclusion that silicone gel implants expose patients to no demonstrable risk for connective tissue or rheumatologic disease.

Both silicone and saline implants have the disadvantages that additional surgery may be necessary, since the implants do not last a lifetime, and that periodic imaging studies may be needed to determine if implant rupture has occurred. (See "Implant based breast reconstruction and augmentation", section on 'Concerns over breast implants'.)

Breast implants are sometimes placed following the use of a tissue expander. In addition, acellular dermal matrix is often used as an adjunct to tissue expander and breast implant reconstructions. This matrix may assist in the shaping of the reconstructive breast and allow tissue expanders to be filled to higher volumes [2].

Issues related to breast implant infections will be reviewed here. Breast cellulitis, which is another form of breast infection related to breast cancer surgery, is discussed separately. (See "Breast cellulitis and other skin disorders of the breast".)

             

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Thu Oct 29 00:00:00 GMT+00:00 2015.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. http://www.plasticsurgery.org/Documents/news-resources/statistics/2011-statistics/2011-cosmetic-procedures-trends-statistics.pdf (Accessed on November 04, 2013).
  2. Chun YS, Verma K, Rosen H, et al. Implant-based breast reconstruction using acellular dermal matrix and the risk of postoperative complications. Plast Reconstr Surg 2010; 125:429.
  3. Kjøller K, Hölmich LR, Jacobsen PH, et al. Epidemiological investigation of local complications after cosmetic breast implant surgery in Denmark. Ann Plast Surg 2002; 48:229.
  4. Gabriel SE, Woods JE, O'Fallon WM, et al. Complications leading to surgery after breast implantation. N Engl J Med 1997; 336:677.
  5. Pyfer B, Chatterjee A, Chen L, et al. Early Postoperative Outcomes in Breast Conservation Surgery Versus Simple Mastectomy with Implant Reconstruction: A NSQIP Analysis of 11,645 Patients. Ann Surg Oncol 2016; 23:92.
  6. Pittet B, Montandon D, Pittet D. Infection in breast implants. Lancet Infect Dis 2005; 5:94.
  7. Brand KG. Infection of mammary prostheses: a survey and the question of prevention. Ann Plast Surg 1993; 30:289.
  8. Olsen MA, Nickel KB, Fox IK, et al. Incidence of Surgical Site Infection Following Mastectomy With and Without Immediate Reconstruction Using Private Insurer Claims Data. Infect Control Hosp Epidemiol 2015; 36:907.
  9. Nahabedian MY, Tsangaris T, Momen B, Manson PN. Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg 2003; 112:467.
  10. De Cholnoky T. Augmentation mammaplasty. Survey of complications in 10,941 patients by 265 surgeons. Plast Reconstr Surg 1970; 45:573.
  11. Zhao X, Wu X, Dong J, et al. A Meta-analysis of Postoperative Complications of Tissue Expander/Implant Breast Reconstruction Using Acellular Dermal Matrix. Aesthetic Plast Surg 2015; 39:892.
  12. Kainer MA, Keshavarz H, Jensen BJ, et al. Saline-filled breast implant contamination with Curvularia species among women who underwent cosmetic breast augmentation. J Infect Dis 2005; 192:170.
  13. Young VL, Hertl MC, Murray PR, et al. Microbial growth inside saline-filled breast implants. Plast Reconstr Surg 1997; 100:182.
  14. Chen NT, Butler PE, Hooper DC, May JW Jr. Bacterial growth in saline implants: in vitro and in vivo studies. Ann Plast Surg 1996; 36:337.
  15. Safranek TJ, Jarvis WR, Carson LA, et al. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med 1987; 317:197.
  16. Petit F, Maladry D, Werther JR, Mitz V. [Late infection of breast implant, complication of colonic perforation. Review of the literature. Role of preventive treatment]. Ann Chir Plast Esthet 1998; 43:559.
  17. Seng P, Bayle S, Alliez A, et al. The microbial epidemiology of breast implant infections in a regional referral centre for plastic and reconstructive surgery in the south of France. Int J Infect Dis 2015; 35:62.
  18. Torres-Coy JA, Rodríguez-Castillo BA, Pérez-Alfonzo R, DE Waard JH. Source investigation of two outbreaks of skin and soft tissue infection by Mycobacterium abscessus subsp. abscessus in Venezuela. Epidemiol Infect 2016; 144:1117.
  19. Haiavy J, Tobin H. Mycobacterium fortuitum infection in prosthetic breast implants. Plast Reconstr Surg 2002; 109:2124.
  20. Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 1982; 146:487.
  21. Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest 1984; 73:1191.
  22. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284:1318.
  23. Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 2001; 33:1387.
  24. Vuong C, Gerke C, Somerville GA, et al. Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis 2003; 188:706.
  25. Thornton JW, Argenta LC, McClatchey KD, Marks MW. Studies on the endogenous flora of the human breast. Ann Plast Surg 1988; 20:39.
  26. Holm C, Mühlbauer W. Toxic shock syndrome in plastic surgery patients: case report and review of the literature. Aesthetic Plast Surg 1998; 22:180.
  27. Shah Z, Lehman JA Jr, Tan J. Does infection play a role in breast capsular contracture? Plast Reconstr Surg 1981; 68:34.
  28. Rudolph R, Woodward M. Absence of visible bacteria in capsules around silicone breast implants. Plast Reconstr Surg 1983; 72:32.
  29. Pajkos A, Deva AK, Vickery K, et al. Detection of subclinical infection in significant breast implant capsules. Plast Reconstr Surg 2003; 111:1605.
  30. Spear SL, Howard MA, Boehmler JH, et al. The infected or exposed breast implant: management and treatment strategies. Plast Reconstr Surg 2004; 113:1634.
  31. Prince MD, Suber JS, Aya-Ay ML, et al. Prosthesis salvage in breast reconstruction patients with periprosthetic infection and exposure. Plast Reconstr Surg 2012; 129:42.
  32. Bennett SP, Fitoussi AD, Berry MG, et al. Management of exposed, infected implant-based breast reconstruction and strategies for salvage. J Plast Reconstr Aesthet Surg 2011; 64:1270.
  33. Kendrick AS, Chase CW. Salvage of an infected breast tissue expander with an implant sizer and negative pressure wound management. Plast Reconstr Surg 2008; 121:138e.
  34. Chun JK, Schulman MR. The infected breast prosthesis after mastectomy reconstruction: successful salvage of nine implants in eight consecutive patients. Plast Reconstr Surg 2007; 120:581.
  35. Washer LL, Gutowski K. Breast implant infections. Infect Dis Clin North Am 2012; 26:111.
  36. Phillips BT, Bishawi M, Dagum AB, et al. A systematic review of antibiotic use and infection in breast reconstruction: what is the evidence? Plast Reconstr Surg 2013; 131:1.
  37. Hardwicke JT, Bechar J, Skillman JM. Are systemic antibiotics indicated in aesthetic breast surgery? A systematic review of the literature. Plast Reconstr Surg 2013; 131:1395.
  38. Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett 2012; 10:73.
  39. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013; 70:195.
  40. Araco A, Gravante G, Araco F, et al. Infections of breast implants in aesthetic breast augmentations: a single-center review of 3,002 patients. Aesthetic Plast Surg 2007; 31:325.
  41. Adams WP Jr, Rios JL, Smith SJ. Enhancing patient outcomes in aesthetic and reconstructive breast surgery using triple antibiotic breast irrigation: six-year prospective clinical study. Plast Reconstr Surg 2006; 117:30.
  42. Stoopler E, Sia YW, Kuperstein A. Do Patients with Solid Organ Transplants or Breast Implants Require Antibiotic Prophylaxis before Dental Treatment? J Can Dent Assoc 2012;78:c5.